a
M

COMPANY

SCIENCE

INVESTORS

Sustainability

CONTACT

Leadership

Oscotec is driven by experienced scientists, clinicians, and business leaders committed to transforming cancer treatment.

RESEARCH TEAM

Driving scientific innovation, drug discovery,
and the development of next-generation oncology therapies.

MANAGEMENT TEAM

Guiding corporate strategy, operations,
partnerships, and sustainable business growth.

Taeyoung Yoon

Chief Executive Officer

  • Ph.D. in Organic Chemistry from Yale Univ.
  • California Inst. of Technology, Post-Doc
  • Novartis Pharma., Principal Scientist
  • Dong-A ST Inc., SVP, Head of Research Center

Sanghyun Lee

Chief Executive Officer

  • Director/Management
  • MBA in Business Administration from Dankook Univ.
RESEARCH TEAM

Driving scientific innovation, drug discovery,
and the development of next-generation oncology therapies.

Taeyoung Yoon

Chief Executive Officer

  • Ph.D. in Organic Chemistry from Yale Univ.
  • California Inst. of Technology, Post-Doc
  • Novartis Pharma., Principal Scientist
  • Dong-A ST Inc., SVP, Head of Research Center
MANAGEMENT TEAM

Guiding corporate strategy, operations,
partnerships, and sustainable business growth.

Sanghyun Lee

Chief Executive Officer

  • Director/Management
  • MBA in Business Administration from Dankook Univ.